UK Cosmetic Regulation Is a 'Confusing Mess', MPs Warn

A cross-party committee of MPs has branded UK cosmetics regulation a "confusing mess" that has "absolutely failed" to keep pace with scientific developments in products and treatments. The Science and Technology Select Committee's report, published this week, found that many hair and beauty products face less regulation than ballpoint pens, despite the complex chemicals they contain.

The verdict lands on a sector that has outgrown its rulebook. Fat dissolvers and skin brighteners have entered the market with no regulatory framework matched to their risk, and the report says enforcement has not kept up with how products are supplied and marketed to consumers.

Dame Chi Onwurah, chair of the committee, said: "Action, not just a consultation, is long overdue, and quick solutions must be found to regulate injectable products like fat dissolvers and skin brighteners, while making sure any regulation doesn't push female-led businesses off the market."

What does the report want restricted?

The committee called on the government to "immediately restrict genital fillers, liquid Brazilian butt lifts (BBLs), and liquid boob jobs (LBJs)" to qualified medical professionals and licensed premises. That is the sharpest recommendation in the report, and it targets the procedures regulators consider highest-risk.

Botox sits in a glaring gap. The product itself is prescription-only, yet no regulation governs who can administer it once prescribed. The committee wants mandatory national training and qualification standards to close that hole.

In plain terms: the report wants the riskiest injectables in licensed medical hands, and consistent training for everyone wielding a needle.

Why do MPs say enforcement is failing?

The report found that illegal and dangerous products now reach UK consumers faster and in greater volumes than regulators can police. Online marketplaces are the main conduit, and the government has legislated to give itself powers to make those platforms responsible for product safety — but has not yet brought in any of the necessary regulatory changes.

The committee's language is blunt. "The government should urgently bring in the changes needed to make online marketplaces responsible for the safety of the products they profit from and introduce meaningful penalties for non-compliance," the report said.

For dermatology practitioners, that means counterfeit or unapproved formulations reaching patients through channels the regulator cannot currently hold accountable.

What role did sexism and racism play?

The report goes further than most regulatory documents. It states that complacency over the lack of effective regulation and enforcement has roots in "sexism and racism", noting that women make up the majority of consumers, practitioners and scientists in the sector.

The committee stressed that new regulation must not reduce the "already limited" access to business of women in general and women of colour in particular. Onwurah said people buying products on the high street should be able to trust that they are safe, properly regulated and provided by someone with the right training.

That framing sets a dual test for policymakers: tighten safety without shutting out the workforce that dominates the sector.

How did the government respond?

A Department of Health and Social Care spokesperson said the government is "committed to protecting the public from rogue practitioners" and has been working with a group of experts to develop tough new measures.

"We are now consulting on these measures which would include restricting all cosmetic surgery to doctors who are regulated to strict standards set by the General Medical Council and who work from Care Quality Commission regulated settings," the spokesperson said.

The government has also committed to introducing a licensing scheme for lower-risk cosmetic procedures such as facial filler, ensuring practitioners are appropriately trained, insured and working to safe standards.

What else did the committee recommend?

Beyond the headline restrictions, the report set out three further measures:

• Improving research into cosmetic products
• Establishing a single point of contact for reporting harm from cosmetic products
• Teaching students about the risks of cosmetic procedures

The committee also welcomed the government's recent consultation on proposals to restrict some high-risk cosmetic procedures, but stressed that action must follow swiftly to address ongoing harms.

Onwurah's closing argument puts science at the centre of the fix. "The cosmetics industry is a science industry, and science must be at the heart of how it's regulated," she said. "This means filling gaps in research, responding more quickly when evidence of harm emerges and explaining risks clearly to the public."

With the consultation open, the sector now waits to see whether restriction of high-risk procedures to GMC-regulated doctors and CQC-regulated settings arrives as legislation or as another round of consultation — a question that will shape who can legally deliver injectable treatments in the UK, and where.